For US Healthcare Professionals Only


Sincalide for Injection, 5 mcg
NDC 72266-0248-01
J-CODE 2806

Coding for hepatobiliary system imaging, including gallbladder, using contrast:

  • Effective July 1, 2023, the Level II HCPCS code for Fosun's Sincalide for Injection is J2806 and it is billed per 5 mcg.
  • The CPT code for a hepatobiliary scan with Sincalide for Injection would be 78227.


If you have any questions,
please call 1-855-282-4882.

Healthcare providers should code healthcare claims based upon the service that is rendered, the patient’s medical record, the coding requirements of each health insurer, and the best coding practices. The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Maia and its agents make no guarantee regarding reimbursement for any service or item.

CPT only copyright 2023 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. 

Important safety information


Sincalide for Injection is a cholecystokinin (CCK) analog indicated in adults to:

  1. Stimulate gallbladder contraction, as may be necessary by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids and crystals.
  2. Stimulate pancreatic secretin in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology.
  3. Accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract.

Important safety information

Warnings and precautions
  • Anaphylaxis, Anaphylactic Shock and Other Hypersensitivity Reactions: May occur during or soon after administration. If symptoms occur, discontinue the drug.
  • Evacuation of Gallstones: Stimulation of gallbladder contraction in patients with small gallbladder stones could lead to the evacuation of the stones from the gallbladder, resulting in their lodging in the cystic duct or in the common bile duct.
  • Gastrointestinal Adverse Reactions with Intravenous Injection: Administration as an intravenous injection may cause transient nausea, vomiting, abdominal pain or cramping, dizziness or flushing. To reduce the risk of adverse reactions when used to simulate contraction of the gallbladder or accelerate transit of a barium meal through the small intestine, administer as an intravenous infusion over 50 or 30 minutes, respectively.
  • Preterm Labor or Spontaneous Abortion: Advise pregnant women of the potential risk for preterm labor and spontaneous abortion.
Adverse reactions

Most common adverse reactions (≥20%) are: abdominal discomfort or pain, and nausea.

Drug interactions

Drugs that Affect Gallbladder Motility or Contractile Response: May interfere with response to Sincalide. Consider discontinuing these drugs prior to administration of Sincalide for Injection, when used to stimulate contraction of the gallbladder.


Please see Full Prescribing Information